DWT
ABMD

Dorsey & Whitney Trust’s Abiomed Inc ABMD Stock Holding History

Dorsey & Whitney Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,276
Closed -$215K – 374
2017
Q3 		$215K Buy
+1,276
New +$193K 0.04% 306
2015
Q2 		– Sell
-2,954
Closed -$211K – 271
2015
Q1 		$211K Buy
+2,954
New +$160K 0.05% 230

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dorsey & Whitney Trust's ABMD Position: Q4 2017 in Review

Dorsey & Whitney Trust sold out of Abiomed Inc (ABMD) in Q4 2017, closing a stake of 1,276 shares — an estimated $215K sold.

Dorsey & Whitney Trust first reported a position in ABMD in Q1 2015 and held it in 2 quarters. The position peaked at $215K in Q3 2017. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Dorsey & Whitney Trust reported no remaining Abiomed Inc position as of Q4 2017 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 1,276 Abiomed Inc shares in Q4 2017, an estimated $215K.
  • Dorsey & Whitney Trust first reported a position in Abiomed Inc in Q1 2015 and held it in 2 quarters.
  • Dorsey & Whitney Trust's Abiomed Inc position peaked at $215K in Q3 2017.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Dorsey & Whitney Trust's 13F filing for Q4 2017, filed 13 Feb 2018.